Integra LifeSciences Holdings Corporation

NASDAQ:IART

Medical - Devices

Healthcare
$13.86 +4.71%

+$0.81 today

Market cap
$1.08B
Beta
1.25
P/E (TTM)
-2.8
EPS (TTM)
-$6.44
52W Low $8.70High $18.26

Volume 0.58M

Average 0.96M

IART Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Integra LifeSciences Holdings CorporationNASDAQ: IART

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 76.95M shares rose 0.6% year over year, ahead of the -0.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.3% from the prior quarter. Over 3 fiscal years it compounded at -2.6% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.6% holds above the trailing-twelve-month pace of -0.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
76.95M+0.3% QoQ
Last fiscal yearDec 2025
76.75M-0.3% YoY
LTMMar 2026
76.73M-0.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.6%——
1 year-0.3%——
3-year CAGR-2.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
76.75M USD
Year-over-year change
-0.3%
4-year CAGR
-2.4%

Weighted Avg Shares vs competitors

How IART compares with its peers on the latest reported figures

  • IART's LTM Mar 2026 weighted avg shares of 76.73M shares is the 6th highest of the 11 companies compared; the peer median is 94.02M shares.
  • Its year-over-year change of -0.1% is the 9th highest of 11, against a peer median of +2.7%.
  • Over three fiscal years its annual growth of -2.6% compares with a peer median of +7.3%.
IART Competitors Peer median
Weighted Avg Shares for IART and competitors
Company Period LTM YoY 3-year CAGR
SNNSmith & Nephew plcFY2025433.42M -1.1%-0.3%
SYKStryker CorporationLTM Jun 2026382.83M +0.3%+0.4%
ATECAlphatec Holdings, Inc.LTM Mar 2026151.36M +5.1%+13.2%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026139.57M +1.9%+14.0%
GMEDGlobus Medical, Inc.LTM Jun 2026135.1M -0.7%+10.4%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202676.73M -0.1%-2.6%
TELATELA Bio, Inc.LTM Jun 202652.94M +36.3%+42.4%
AXGNAxoGen, Inc.LTM Sep 202651.75M +14.0%+3.0%
AORTArtivion, Inc.LTM Mar 202646.79M +11.6%+4.2%
OFIXOrthofix Medical Inc.LTM Mar 202639.93M +3.4%+25.7%
CNMDCONMED CorporationLTM Mar 202630.87M -0.0%+1.1%
Peer median (excluding IART) 94.02M+2.7%+7.3%

Competitors are the stored peer set for IART. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.54B1.56B1.54B1.61B1.64B
Cost of Revenue597.81M587.36M656.84M728.47M790.01M
Gross Profit944.64M970.31M884.74M882.06M845.23M
Gross Margin61.2%62.3%57.4%54.8%51.7%
Research & Development93.05M101.19M104.19M115.38M98.97M
Selling, General & Admin637.45M616.32M656.64M716.98M699.7M
Operating Expenses747.41M731.39M773.21M853.65M776.92M
Depreciation & Amortization123.67M121.12M123.51M140.5M151.05M
EBITDA366.33M384.6M255.96M193.29M(326.2M)
EBITDA Margin23.7%24.7%16.6%12.0%-19.9%
Operating Income197.23M238.92M111.53M28.41M68.32M
Operating Margin12.8%15.3%7.2%1.8%4.2%
Interest Income6.74M11.92M17.2M20.04M18.47M
Interest Expense50.4M49.59M51.38M70.63M86.26M
Other Income / Expenses17.45M(25.03M)(30.46M)(46.65M)(631.82M)
Income Before Tax214.68M213.89M81.07M(18.24M)(563.5M)
Pre-Tax Margin13.9%13.7%5.3%-1.1%-34.5%
Income Tax Expense45.6M33.34M13.33M(11.29M)(47.03M)
Net Income169.08M180.55M67.74M(6.94M)(516.47M)
Net Margin11.0%11.6%4.4%-0.4%-31.6%
EPS (Basic)2.002.180.87(0.09)(6.73)
EPS (Diluted)1.982.160.84(0.09)(6.73)
Weighted Avg Shares84.7M83M78.17M77.01M76.75M
Weighted Avg Shares (Diluted)85.49M83.52M80.34M77.01M76.75M

Integra LifeSciences Holdings Corporation

NASDAQ:IART

Intrinsic Alpha fair value

Locked

Current Price

$13.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.